Adjuvant pembrolizumab extends disease-free survival in kidney cancer patients
Interim results from a phase 3 clinical trial called KEYNOTE-564 [...]
Interim results from a phase 3 clinical trial called KEYNOTE-564 [...]
This study looked at the use of pegilodecakin alone or [...]
Following suspensions by some countries of the COVID-19 Oxford AstraZeneca [...]
In an attempt to reduce treatment backlogs and hospital visits, [...]
The European Commission has approved the use of the nivolumab [...]
Cancer Research UK conducted a survey with cancer patients from [...]
We at Kidney Cancer Support Network are part of the [...]
The US Food and Drug Administration (FDA) has granted priority [...]
Governments across the UK have bold ambitions to improve cancer [...]
Kidney cancers frequently have mutations in the von Hippel-Lindau (VHL) gene, [...]